Stay updated on G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedUpdated the Locations section with additions and removals of state locations and updated the page revision to v3.3.3.SummaryDifference0.6%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2; no changes to the study details, eligibility criteria, or outcomes are evident on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedRemoved the government funding and operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedNo significant changes detected in the Study Details page for NCT03455270; the study design, eligibility criteria, locations, and outcomes remain unchanged.SummaryDifference0.4%

- Check93 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference4%

- Check100 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.